Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma

PLoS ONE

Volumn 10, Issue 1, 2015, Pages

  Fukushima, Hiroshi ^a   Yokoyama, Minato ^a   Nakanishi, Yasukazu ^a   Tobisu, Ken Ichi ^a   Koga, Fumitaka ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN; LACTATE DEHYDROGENASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS RESECTION; OVERALL SURVIVAL; PREDICTION; RETROSPECTIVE STUDY; SARCOPENIA; TRANSITIONAL CELL CARCINOMA; URINARY TRACT CARCINOMA; BIOLOGICAL MODEL; CACHEXIA; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FOLLOW UP; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; RADIOGRAPHY; SURVIVAL RATE; URINARY TRACT TUMOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CACHEXIA; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SARCOPENIA; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; UROLOGIC NEOPLASMS;

EID: 84921723274     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115895     Document Type: Article

References (30)

1. Argiles JM, Lopez-Soriano FJ, Busquets S (2012) Counteracting inflammation: a promising therapy in cachexia. Crit Rev Oncog 17:253-62. doi: 10.1615/CritRevOncog.v17.i3.30 PMID: 22831156
2. Muliawati Y, Haroen H, Rotty LW (2012) Cancer anorexia-cachexia syndrome. Acta Med Indones 44:154-62. PMID: 22745148
3. Fearon KC, Voss AC, Hustead DS (2006) Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 83:1345-50. PMID: 16762946
4. Saito K, Kihara K (2013) Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes. Int J Urol 20:161-71. doi: 10.1111/j.1442-2042.2012.03121.x PMID: 22897628
5. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, et al. (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9:629-35. doi: 10.1016/S1470-2045(08)70153-0 PMID: 18539529
6. Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, et al. (2013) Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31:1539-47. doi: 10.1200/JCO.2012.45.2722 PMID: 23530101
7. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, et al. (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12:489-95. doi: 10.1016/S1470-2045(10) 70218-7 PMID: 21296615
8. Safer U, Tasci I, Safer VB, Doruk H (2013) Accurate diagnosis of sarcopenia in the elderly requires correct measurement of muscle mass. Clin Nutr 32:662. doi: 10.1016/j.clnu.2013.03.006 PMID: 23587735
9. Shen W, Punyanitya M, Wang Z, Gallagher D, St-Onge MP, et al. (2004) Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol (1985) 97:2333-8. doi: 10.1152/japplphysiol.00744.2004 PMID: 15310748
10. Harimoto N, Shirabe K, Yamashita YI, Ikegami T, Yoshizumi T, et al. (2013) Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg 100:1523-30. doi: 10.1002/bjs.9258 PMID: 24037576
11. Sabel MS, Lee J, Cai S, Englesbe MJ, Holcombe S, et al. (2011) Sarcopenia as a prognostic factor among patients with stage III melanoma. Ann Surg Oncol 18:3579-85. doi: 10.1245/s10434-011-1976-9 PMID: 21822551
12. Bellmunt J, von der Maase H, Mead GM, Skoneczna I, De Santis M, et al. (2012) Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987. J Clin Oncol 30:1107-13. doi: 10.1200/JCO.2011.38.6979 PMID: 22370319
13. Bellmunt J, Choueiri TK, Fougeray R, Schutz FA, Salhi Y, et al. (2010) Prognostic factors in patients with advanced transitional cell carcinoma of the urothelial tract experiencing treatment failure with plati-num-containing regimens. J Clin Oncol 28:1850-5. doi: 10.1200/JCO.2009.25.4599 PMID: 20231682
14. Abe T, Shinohara N, Harabayashi T, Sazawa A, Maruyama S, et al. (2007) Impact of multimodal treatment on survival in patients with metastatic urothelial cancer. Eur Urol 52:1106-13. doi: 10.1016/j. eururo.2007.02.052 PMID: 17367917
15. Ishioka J, Saito K, Sakura M, Yokoyama M, Matsuoka Y, et al. (2012) Development of a nomogram incorporating serum C-reactive protein level to predict overall survival of patients with advanced urothelial carcinoma and its evaluation by decision curve analysis. Br J Cancer 107:1031-6. doi: 10.1038/bjc. 2012.254 PMID: 22918396
16. Bajorin DF, Dodd PM, Mazumdar M, Fazzari M, McCaffrey JA, et al. (1999) Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy. J Clin Oncol 17:3173-81. PMID: 10506615
17. Antoun S, Lanoy E, Iacovelli R, Albiges-Sauvin L, Loriot Y, et al. (2013) Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies. Cancer 119:3377-84. doi: 10.1002/cncr.28218 PMID: 23801109
18. Fearon KC, Glass DJ, Guttridge DC (2012) Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab 16:153-66. doi: 10.1016/j.cmet.2012.06.011 PMID: 22795476
19. Hanahan D, Coussens LM (2012) Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21:309-22. doi: 10.1016/j.ccr.2012.02.022 PMID: 22439926
20. Mamlouk S, Wielockx B (2013) Hypoxia-inducible factors as key regulators of tumor inflammation. Int J Cancer 132:2721-9. doi: 10.1002/ijc.27901 PMID: 23055435
21. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, Lyons W, Gallagher D, et al. (1998) Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol (1985) 85:115-22. PMID: 9655763
22. Antoun S, Baracos VE, Birdsell L, Escudier B, Sawyer MB (2010) Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma. Ann Oncol 21:1594-8. doi: 10.1093/annonc/mdp605 PMID: 20089558
23. Prado CM, Baracos VE, McCargar LJ, Mourtzakis M, Mulder KE, et al. (2007) Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res 13:3264-8. doi: 10.1158/1078-0432.CCR-06-3067 PMID: 17545532
24. Cosqueric G, Sebag A, Ducolombier C, Thomas C, Piette F, et al. (2006) Sarcopenia is predictive of nosocomial infection in care of the elderly. Br J Nutr 96:895-901. doi: 10.1017/BJN20061943 PMID: 17092379
25. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, et al. (2006) Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295:1549-55. doi: 10.1001/jama.295.13.1549 PMID: 16595758
26. Chung JY, Kang HT, Lee DC, Lee HR, Lee YJ (2013) Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity. Arch Gerontol Geriatr 56:270-8. doi: 10.1016/j.archger.2012.09.007 PMID: 23079031
27. Lim S, Kim JH, Yoon JW, Kang SM, Choi SH, et al. (2010) Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care 33:1652-4. doi: 10.2337/dc10-0107 PMID: 20460442
28. Tan BH, Birdsell LA, Martin L, Baracos VE, Fearon KC (2009) Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 15:6973-9. doi: 10.1158/ 1078-0432.CCR-09-1525 PMID: 19887488
29. WHO Expert Consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157-63. doi: 10.1016/S0140-6736(03)15268-3 PMID: 14726171
30. Wulan SN, Westerterp KR, Plasqui G (2010) Ethnic differences in body composition and the associated metabolic profile: a comparative study between Asians and Caucasians. Maturitas 65:315-9. doi: 10. 1016/j.maturitas.2009.12.012 PMID: 20079586